Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 29 Dec 2021 for Dicerna Pharmaceuticals Inc, €235k.
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Shreeram Aradhye: trading record in brief
All filings by Shreeram Aradhye on record concern Dicerna Pharmaceuticals Inc, in the capacity of senior executive. The record holds 5 filings, for trades running from 15 September 2021 to 28 December 2021.
No open-market purchase appears, only 1 sale worth €38k. Other entries cover 1 share grant and 2 option exercises.
Most recently, on 29 December 2021, the filings show a transaction worth €235k in Dicerna Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Shreeram Aradhye
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
6,973 shares@ US$38.25100.0% of flowCommon StockSEC:0001399529-21-000193:0
2,837 sharesCommon StockSEC:0001399529-21-000176:0
7,025 sharesCommon StockSEC:0001399529-21-000149:0
3 of 3 declarations
